Product Description: LDN-192960 is an inhibitor of Haspin and Dual-specificity Tyrosine-regulated Kinase 2 (DYRK2) with IC50s of 10 nM and 48 nM, respectively[1].
Applications: Cancer-Kinase/protease
Formula: C18H20N2O2S
Citations: Universidad de Córdoba. 2023 Sep 11./Bioorg Chem. 2024 Apr 29:147:107412.
References: [1]Cuny GD, et al. Structure-activity relationship study of acridine analogs as haspin and DYRK2 kinase inhibitors. Bioorg Med Chem Lett. 2010 Jun 15;20(12):3491-4./[2]Katrin Kestav, et al. Structure, Roles and Inhibitors of a Mitotic Protein Kinase Haspin. Curr Med Chem. 2017;24(21):2276-2293.
CAS Number: 184582-62-5
Molecular Weight: 328.43
Compound Purity: 99.56
Research Area: Cancer
Solubility: DMSO : 25 mg/mL (ultrasonic)
Target: DYRK;Haspin Kinase